Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer

Epidermal growth factor receptor (EGFR) mutations are common driver genes in nonsmall-cell lung cancer and have different sensitivities to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). EGFR is divided into classic mutations and rare mutations. Classic mutations are well known, but the understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Limeng, Wang, Ruilin, Zhao, Yuhua, Wu, Yingxi, Wang, Lili, Chen, Haiyang, He, Zhen, Wang, Qiming, Wu, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Screening, Diagnosis, and Treatment of Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126640/
https://www.ncbi.nlm.nih.gov/pubmed/37078129
http://dx.doi.org/10.1177/15330338231168466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126640/
https://www.ncbi.nlm.nih.gov/pubmed/37078129
http://dx.doi.org/10.1177/15330338231168466

Ejemplares similares